POCT Urinalysis
[POCT Urinalysis]
EPTIS Ringversuch Nr. 142652 | Letze Änderung 2024-05-22 | URL: https://www.eptis.bam.de/pts142652 https://www.eptis.bam.de/pts142652
| Name des Anbieters | |||||||||||||||||||||||||||||||||||||||||||
| Name des Anbieters | Weqas Weqas | ||||||||||||||||||||||||||||||||||||||||||
| Ansässig in | United Kingdom | ||||||||||||||||||||||||||||||||||||||||||
| Sprache(n) | |||||||||||||||||||||||||||||||||||||||||||
| Anmerkungen | Urinalysis are an array of tests undertaken on a sample of urine to screen and assess a wide range of disorders, including Urinary Tract Infection, Kidney Disease, Liver or biliary disease and Diabetes. Point of care (POC) Urinalysis tends to refer to the first two testing phases and does not include microscopy. Specific strips (cartridges) are also used for the determination of Urinary albumin, often termed microalbumin, and the Albumin/Creatinine ratio as part of the assessment of kidney disease. The base material is fresh filtered human urine, to which additional analytes such as leucocytes, nitrites, ketones, blood, protein, albumin, bilirubin and glucose are added at an appropriate physiological range to reflect the concentration range in clinical samples. 5mL volume of human urine is distributed bimonthly, with a minimum of 6 samples distributed over the year covering a clinically relevant range for screening. Both manual and automated POCT device results can be submitted as qualitative (neg, pos, or +,++,+++) or semiquantitative results (e.g. range band 2-5mmol/l). Key Features: - Material is commutable with all Urinalysis strips and meters. - Suitable for manual or automated devices. - Quantitative, semiquantitative and qualitative results are accommodated. - Qualitative drop down fields on website customised for each instrument / strip. - Liquid human urine samples requiring no pre-analytical preparation. - Concentration of analytes at clinically relevant range. For more information: https://www.weqas.com/services/poct-eqa/poct-urinalysis/ or contact@weqas.com | ||||||||||||||||||||||||||||||||||||||||||
| Klassifizierung | |||||||||||||||||||||||||||||||||||||||||||
| Produktgruppen |
Health care / medical devices
|
||||||||||||||||||||||||||||||||||||||||||
| Prüfgebiete |
Medical analysis
|
||||||||||||||||||||||||||||||||||||||||||
| Technische Einzelheiten | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
| Ringversuchsziele | |||||||||||||||||||||||||||||||||||||||||||
| Zielgruppe des Ringversuchs | Aims to assess the performance and reliability of organisations undertaking POC Urinalysis tests in a wide variety of healthcare situations. | ||||||||||||||||||||||||||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | Accreditation by UKAS based on ISO/IEC 17043. | ||||||||||||||||||||||||||||||||||||||||||
| Weitere Ziele | validation of testing methods | ||||||||||||||||||||||||||||||||||||||||||
| Teilnehmerzahl | |||||||||||||||||||||||||||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/IEC 17043 |
||||||||||||||||||||||||||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||||||||||||||||||||||||||||||||||||||
| Kosten | |||||||||||||||||||||||||||||||||||||||||||
| Teilnahmegebühr | https://www.weqas.com/participantzone/subscription-charges/ | ||||||||||||||||||||||||||||||||||||||||||
| Regelmässig durchgeführt | Ja (Frequency: Bimonthly. Samples: 1 x 5.0mL) | ||||||||||||||||||||||||||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | 1997 | ||||||||||||||||||||||||||||||||||||||||||
| Kontaktdaten des Anbieters | |||||||||||||||||||||||||||||||||||||||||||
| Anbieter | Kontaktperson | ||||||||||||||||||||||||||||||||||||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Telefon: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 32884 Fax: E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
||||||||||||||||||||||||||||||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.